Skip to main content
S 2562 107th Congress Senate Health Agriculture and Food Ambulatory care Animal genetics Animals Clinical trials Congress Congressional investigations Congressional reporting requirements Department of Health and Human Services Digestive diseases Drug therapy Education Environmental Protection Environmental health Epidemiology Genetic research Government Operations and Politics Governmental investigations Health education

Inflammatory Bowel Disease Act

Introduced: May 23, 2002 See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 107th Congress ended
It never became law before the 107th Congress (2001–2002) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 23, 2002
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S4852)
May 23, 2002
Sponsor introductory remarks on measure. (CR S4851-4852)
May 23, 2002
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service
Inflammatory Bowel Disease Act - Requires the Director of the National Institute of Diabetes and Digestive and Kidney Diseases to expand activities addressing inflammatory bowel disease, emphasizing genetic, animal model, and clinical research.

Requires the Director of the Centers for Disease Control and Prevention to establish a national program of prevention and epidemiology concerning such disease, addressing its prevalence and public and professional awareness.

Directs the Institute of Medicine of the National Academies of Science to study public and private insurance standards for coverage of inflammatory bowel therapies.

Directs the General Accounting Office to study problems inflammatory bowel disease patients have applying for disability insurance benefits under the Social Security Act.

What's happening now May 23, 2002

Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S4852)

 Related & companion bills 1
  • HR 5031 Identical bill Inflammatory Bowel Disease Act
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 2
All 2 Democratic 1 Republican 1
R
Collins, Susan M.
Maine · Nov 19, 2002
 D
Schumer, Charles E.
New York · Jul 23, 2002
Cite this page click to expand
APA
U.S. Congress. (2026). S. 2562: Inflammatory Bowel Disease Act. 107th Congress. Open America. https://openamerica.io/bill/107-S-2562/
MLA
"S. 2562: Inflammatory Bowel Disease Act." 107th Congress, 2026, Open America, https://openamerica.io/bill/107-S-2562/.
Bluebook (legal)
S. 2562, 107th Cong. (2026), https://openamerica.io/bill/107-S-2562/.
Markdown link
[S. 2562: Inflammatory Bowel Disease Act](https://openamerica.io/bill/107-S-2562/)
Report a problem